Male (N-26) | Female (N-49) | p Value (M vs F) | All (N-75) | |
---|---|---|---|---|
Age (median, IQR) | 26.50 (21.75–40.25) | 24.00 (17.50–34.00) | 0.08 | 25.00 (19.00–35.00) |
Ethnicity (n) | ||||
Indigenous | 24 | 49 | – | 73 |
Non-indigenous | 2 | 0 | – | 2 |
DGI n (%) | ||||
Proven | 17 (65%) | 25 (51%) | 42 (56%) | |
Probable | 4 (15%) | 15 (31%) | 0.34 | 19 (25%) |
Possible | 5 (19%) | 9 (18%) | 14 (19%) | |
Length of stay (mean days±SD) | 8.68±5.4 | 8.39±5.03 | 0.81 | 8.49±5.11 |
Self—Discharge n (%) | 4 (15%) | 12 (24%) | 0.55 | 16 (21%) |
Clinical presentation | ||||
Tenosynovitis n (%) | 4 (15%) | 6 (12%) | 0.70 | 10 (13%) |
Dermatitis n (%) | 0 (0%) | 1 (2%) | 0.46 | 1 (1%) |
Polyarthritis n (%) | 10 (38%) | 17 (35%) | 0.75 | 27 (36%) |
Clinical triad n | 0 | 0 | – | 0 |
Joint arthralgia | ||||
Knee n (%) | 10 (38%) | 17 (35%) | 0.75 | 27 (36%) |
Wrist n (%) | 6 (23%) | 7 (14%) | 0.35 | 13 (17%) |
Ankle n (%) | 4 (15%) | 9 (18%) | 1.0 | 13 (17%) |
Elbow n (%) | 3 (12%) | 5 (10%) | 0.52 | 8 (11%) |
Fever on admission n (%) | 9 (35%) | 15 (31%) | 0.79 | 24 (32%) |
Comorbidities n (%) | ||||
Diabetes | 6 (23%) | 10 (20%) | 0.76 | 16 (21%) |
Alcohol abuse | 7 (27%) | 9 (18%) | 0.39 | 16 (21%) |
PID | 0 (0%) | 7 (14%) | – | 7 (9%) |
p Values represent comparisons between men and women within this cohort.
DGI, disseminated gonococcal infection; PID, pelvic inflammatory disease.